Linezolid (LZD) is a synthetic oxazolidinone antibiotic indicated for the treatment of serious infections caused by methicillin-resistant or vancomycin-resistant Gram-positive bacteria. It is also utilized in the management of drug-resistant tuberculosis, where it demonstrates excellent early bactericidal activity.

AccuSift provides high-performance competitive antibody pairs for linezolid detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 10 ng/mL